https://wikem.org/w/index.php?action=history&feed=atom&title=Tirofiban 2026-04-18T01:01:13Z Revision history for this page on the wiki MediaWiki 1.38.2 https://wikem.org/w/index.php?title=Tirofiban&diff=299728&oldid=prev 2021-03-06T03:03:39Z

<p><span dir="auto"><span class="autocomment">See Also</span></span></p> <table style="background-color: #fff; color: #202122;" data-mw="interface"> <col class="diff-marker" /> <col class="diff-content" /> <col class="diff-marker" /> <col class="diff-content" /> <tr class="diff-title" lang="es"> <td colspan="2" style="background-color: #fff; color: #202122; text-align: center;">← Revisión anterior</td> <td colspan="2" style="background-color: #fff; color: #202122; text-align: center;">Revisión del 03:03 6 mar 2021</td> </tr><tr><td colspan="2" class="diff-lineno" id="mw-diff-left-l68">Línea 68:</td> <td colspan="2" class="diff-lineno">Línea 68:</td></tr> <tr><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><br/></td><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><br/></td></tr> <tr><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>==See Also==</div></td><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>==See Also==</div></td></tr> <tr><td class="diff-marker" data-marker="−"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div> </div></td><td class="diff-marker" data-marker="+"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div><ins style="font-weight: bold; text-decoration: none;">*[[Antiplatelet medications]]</ins></div></td></tr> <tr><td colspan="2" class="diff-side-deleted"></td><td class="diff-marker" data-marker="+"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div><ins style="font-weight: bold; text-decoration: none;">*[[Antiplatelet agent reversal]]</ins></div></td></tr> <tr><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><br/></td><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><br/></td></tr> <tr><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>==References==</div></td><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>==References==</div></td></tr> </table>

Elcatracho https://wikem.org/w/index.php?title=Tirofiban&diff=229755&oldid=prev 2019-09-23T23:03:11Z

<p><span dir="auto"><span class="autocomment">Pregnancy Rating</span></span></p> <table style="background-color: #fff; color: #202122;" data-mw="interface"> <col class="diff-marker" /> <col class="diff-content" /> <col class="diff-marker" /> <col class="diff-content" /> <tr class="diff-title" lang="es"> <td colspan="2" style="background-color: #fff; color: #202122; text-align: center;">← Revisión anterior</td> <td colspan="2" style="background-color: #fff; color: #202122; text-align: center;">Revisión del 23:03 23 sep 2019</td> </tr><tr><td colspan="2" class="diff-lineno" id="mw-diff-left-l14">Línea 14:</td> <td colspan="2" class="diff-lineno">Línea 14:</td></tr> <tr><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>==Special Populations==</div></td><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>==Special Populations==</div></td></tr> <tr><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>===[[Drug pregnancy categories|Pregnancy Rating]]===</div></td><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>===[[Drug pregnancy categories|Pregnancy Rating]]===</div></td></tr> <tr><td colspan="2" class="diff-side-deleted"></td><td class="diff-marker" data-marker="+"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div><ins style="font-weight: bold; text-decoration: none;">*Category B</ins></div></td></tr> <tr><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>*Benefits outweigh risks during pregnancy</div></td><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>*Benefits outweigh risks during pregnancy</div></td></tr> <tr><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>*Risk of maternal hemorrhage during delivery</div></td><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>*Risk of maternal hemorrhage during delivery</div></td></tr> </table>

ClaireLewis https://wikem.org/w/index.php?title=Tirofiban&diff=187169&oldid=prev 2018-07-26T04:02:23Z

<p>Creation of page</p> <p><b>Página nueva</b></p><div>==Administration==<br /> *Type: [[Antiplatelet]]<br /> *Dosage Forms: INJ<br /> *Routes of Administration: IV<br /> *Common Trade Names: Aggrastat<br /> <br /> ==Adult Dosing==<br /> ===[[Acute coronary syndrome]], Non ST-elevation===<br /> *25 mcg/kg IV x1, then 0.15 mcg/kg/min IV for up to 18h<br /> <br /> ==Pediatric Dosing==<br /> Safety/efficacy not established in pediatric patients<br /> <br /> ==Special Populations==<br /> ===[[Drug pregnancy categories|Pregnancy Rating]]===<br /> *Benefits outweigh risks during pregnancy<br /> *Risk of maternal hemorrhage during delivery<br /> *Risk of fetal bleeding<br /> <br /> ===Lactation risk===<br /> *Caution advised while breastfeeding<br /> <br /> ===Renal Dosing===<br /> *Adult:<br /> **CrCl &lt;60: Decrease maintenance infusion rate 50%<br /> **HD: Not defined<br /> *Pediatric: Unavailable<br /> <br /> ===Hepatic Dosing===<br /> *Adult: Not defined<br /> *Pediatric: Unavailable<br /> <br /> ==Contraindications==<br /> *Allergy to class/drug<br /> *[[Thrombocytopenia]] with prior use<br /> *Active bleeding<br /> *Coagulation disorder w/in 30 days<br /> *Major trauma or surgery w/in 30 days<br /> <br /> ==Adverse Reactions==<br /> ===Serious===<br /> *[[Anaphylaxis]]<br /> *Bleeding, severe<br /> *[[Intracranial hemorrhage]]<br /> *Intraocular hemorrhage<br /> *Retroperitoneal bleeding<br /> *[[Thrombocytopenia]], severe<br /> *[[Coronary artery dissection]]<br /> <br /> ===Common===<br /> *Bleeding<br /> *Pelvic pain<br /> *[[Bradycardia]]<br /> *Edema, Leg pain<br /> *[[Dizziness]], Diaphoresis<br /> <br /> ==Pharmacology==<br /> *Half-life: 2 hour<br /> *Metabolism: Minimal<br /> *Excretion: Urine 65%, feces 25% (primarily unchanged)<br /> <br /> ==Mechanism of Action==<br /> *Reversibly binds to platelet glycoprotein IIb/IIIa receptors, reducing platelet aggregation<br /> <br /> ==Comments==<br /> <br /> <br /> ==See Also==<br /> <br /> <br /> ==References==<br /> &lt;references/&gt;<br /> <br /> [[Category:Pharmacology]]</div>

Jonwarren